Search Results - "Teshima, Rie"

Aggregatibacter actinomycetemcomitans infection causes DNA double‐strand breaks in host cells by Teshima, Rie, Hanada, Katsuhiro, Akada, Junko, Kawano, Kenji, Yamaoka, Yoshio

“…Periodontal disease, an inflammatory disease, is caused by infection with periodontal pathogens. Long‐term periodontal disease increases the risk of oral…”
Get full text

Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan by Ohno-Matsui, Kyoko, Suzaki, Makoto, Teshima, Rie, Okami, Nina

“…Objectives The aim of this study was to obtain real-world clinical data on the safety and efficacy of ranibizumab treatment for myopic choroidal…”
Get full text

Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab by Morita, Akimichi, Tani, Yumiko, Matsumoto, Kazuko, Yamaguchi, Masako, Teshima, Rie, Ohtsuki, Mamitaro

“…The molecular basis of interleukin (IL)‐17A in driving psoriasis pathogenesis is not fully elucidated yet. To investigate the underlying mechanisms and…”
Get full text

Detection of DNA double‐strand breaks by pulsed‐field gel electrophoresis by Kawashima, Yuri, Yamaguchi, Nahomi, Teshima, Rie, Narahara, Hisashi, Yamaoka, Yoshio, Anai, Hirofumi, Nishida, Yoshihiro, Hanada, Katsuhiro

“…A DNA double‐strand break (DSB) is one of the most cytotoxic DNA lesions because unrepaired DSBs cause chromosomal aberrations and cell death. Although many…”
Get full text

Secukinumab improves psoriasis symptoms in patients with inadequate response to cyclosporine A: A prospective study to evaluate direct switch by Ohtsuki, Mamitaro, Morita, Akimichi, Igarashi, Atsuyuki, Imafuku, Shinichi, Tada, Yayoi, Fujita, Hiroyuki, Fujishige, Ayako, Yamaguchi, Masako, Teshima, Rie, Tani, Yumiko, Nakagawa, Hidemi

“…There are limited data on the safety and efficacy of switching to secukinumab from cyclosporine A (CyA) in patients with psoriasis. The purpose of the present…”
Get full text

Oxcarbazepine adjunctive therapy for partial seizures in Japanese pediatric patients: a randomized double-blind placebo-controlled study and open-label extension study by Fujiwara, Tateki, Teshima, Rie, Sugiyama, Ikuo, Tsuchida, Ken, Ohtsuka, Yoko

“…Purpose: To assess the efficacy, safety, and pharmacokinetics of oxcarbazepine (OXC) as an adjunctive therapy in Japanese pediatric patients with inadequately…”
Get full text

Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT): Japanese cohort data by Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Katsuno, Masahisa, Murata, Kenya, Nodera, Hiroyuki, Teshima, Rie, Inamura, Tatsumi, Nishino, Ichizo, Aoki, Masashi

“…A global, randomized, double-blind placebo-controlled study was conducted to confirm that BYM338 (bimagrumab), an anti-activin type II receptor antibody,…”
Get more information

16S METAGENOMIC ANALYSIS OF INTRATUMORAL BACTERIAL FLORA IN ORAL CANCER PATIENTS by TESHIMA, RIE, MATSUMOTO, TAKASHI, KAWANO, KENJI, YAMAOKA, YOSHIO

Get full text

Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results by Takahashi, Kota, Uchida, Kazuharu, Yoshimura, Norio, Takahara, Shiro, Teraoka, Satoshi, Teshima, Rie, Cornu-Artis, Catherine, Kobayashi, Eiji

“…No study to date has evaluated the efficacy and safety of everolimus with reduced-exposure cyclosporine in Japanese de-novo renal transplant (RTx) patients…”
Get full text